1-7 of 7
Christian Klein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B004: Identifying response factors to PD1-IL2v therapy

Free
Amrita Manchala, Eleni Maria Varypataki, Maria Karagianni, Elzbieta Gralinska, Christian Münz, Christian Klein, Jehad Charo, Laura Codarri Deak
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (10_Supplement): B004.
https://doi.org/10.1158/2326-6074.TUMIMM24-B004
Published: 18 October 2024
View articletitled, Abstract B004: Identifying response factors to PD1-IL2v therapy
Journal Articles

Abstract A054: Recruiting innate immune cells universally: Development of a novel universal innate cell engager for cancer-immunotherapy

Free
Idil Hutter-Karakoc, Marlena Surowka, Diana Darowski, Christina Klaus, Claudia Ferrara Koller, Thomas Hofer, Anne Freimoser-Grundschober, Ekkehard Mössner, Stephane Leclair, Pablo Umana, Christian Munz, Maria Amann, Christian Klein
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (10_Supplement): A054.
https://doi.org/10.1158/2326-6074.TUMIMM24-A054
Published: 18 October 2024
View articletitled, Abstract A054: Recruiting innate immune cells universally: Development of a novel universal innate cell engager for cancer-immunotherapy
Journal Articles

In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 Therapies

Available to Purchase
Morgane Denis, Chloé Grasselly, Pierre-Antoine Choffour, Anne Wierinckx, Doriane Mathé, Kamel Chettab, Anne Tourette, Nolan Talhi, Aurore Bourguignon, Fabian Birzele, Elsa Kress, Lars Petter Jordheim, Christian Klein, Eva-Laure Matera, Charles Dumontet
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (8): 1013–1027.
https://doi.org/10.1158/2326-6066.CIR-21-0802
Published: 03 August 2022
View articletitled, In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 Therapies
Open the PDF for In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 Therapies in another window
Includes: Supplementary data
Journal Articles

Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia

Free
Priyanka Banerjee, Ronghua Zhang, Cristina Ivan, Giovanni Galletti, Karen Clise-Dwyer, Federica Barbaglio, Lydia Scarfò, Miguel Aracil, Christian Klein, William Wierda, William Plunkett, Federico Caligaris-Cappio, Varsha Gandhi, Michael J. Keating, Maria Teresa S. Bertilaccio
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (12): 2036–2051.
https://doi.org/10.1158/2326-6066.CIR-19-0152
Published: 02 December 2019
View articletitled, Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia
Open the PDF for Trabectedin Reveals a Strategy of Immunomodulation in Chronic Lymphocytic Leukemia in another window
Includes: Supplementary data
Journal Articles

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors

Free
Daniela S. Thommen, Jens Schreiner, Philipp Müller, Petra Herzig, Andreas Roller, Anton Belousov, Pablo Umana, Pavel Pisa, Christian Klein, Marina Bacac, Ozana S. Fischer, Wolfgang Moersig, Spasenija Savic Prince, Victor Levitsky, Vaios Karanikas, Didier Lardinois, Alfred Zippelius
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2015) 3 (12): 1344–1355.
https://doi.org/10.1158/2326-6066.CIR-15-0097
Published: 06 December 2015
View articletitled, Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
Open the PDF for Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors in another window
Includes: Supplementary data
Journal Articles

Abstract IA07: Enhancing immune effector function via antibody engineering

Free
Christian Klein
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (10_Supplement): IA07.
https://doi.org/10.1158/2326-6074.TUMIMM14-IA07
Published: 09 October 2015
View articletitled, Abstract IA07: Enhancing immune effector function via antibody engineering
Journal Articles

Committing Cytomegalovirus-Specific CD8 T Cells to Eliminate Tumor Cells by Bifunctional Major Histocompatibility Class I Antibody Fusion Molecules

Free
Martina Schmittnaegel, Victor Levitsky, Eike Hoffmann, Guy Georges, Olaf Mundigl, Christian Klein, Hendrik Knoetgen
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2015) 3 (7): 764–776.
https://doi.org/10.1158/2326-6066.CIR-15-0037
Published: 01 July 2015
View articletitled, Committing Cytomegalovirus-Specific CD8 T Cells to Eliminate Tumor Cells by Bifunctional Major Histocompatibility Class I Antibody Fusion Molecules
Open the PDF for Committing Cytomegalovirus-Specific CD8 T Cells to Eliminate Tumor Cells by Bifunctional Major Histocompatibility Class I Antibody Fusion Molecules in another window
Includes: Multimedia, Supplementary data